Zacks: Brokerages Expect Cantel Medical Corp. (NYSE:CMD) Will Post Quarterly Sales of $238.60 Million

Brokerages predict that Cantel Medical Corp. (NYSE:CMD) will report $238.60 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Cantel Medical’s earnings, with estimates ranging from $236.70 million to $240.50 million. Cantel Medical reported sales of $228.85 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 4.3%. The company is scheduled to issue its next earnings results on Thursday, September 26th.

On average, analysts expect that Cantel Medical will report full-year sales of $917.30 million for the current fiscal year, with estimates ranging from $915.30 million to $919.30 million. For the next fiscal year, analysts forecast that the company will post sales of $985.20 million, with estimates ranging from $977.70 million to $992.70 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Cantel Medical.

Cantel Medical (NYSE:CMD) last released its quarterly earnings data on Tuesday, June 4th. The company reported $0.55 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.55. The firm had revenue of $228.55 million during the quarter, compared to the consensus estimate of $225.95 million. Cantel Medical had a return on equity of 15.52% and a net margin of 6.95%.

Shares of NYSE CMD traded up $0.48 during midday trading on Friday, hitting $89.20. 102,200 shares of the stock traded hands, compared to its average volume of 229,805. The company has a market cap of $3.73 billion, a PE ratio of 35.54 and a beta of 1.11. Cantel Medical has a one year low of $63.47 and a one year high of $99.68. The business has a 50 day moving average price of $83.94 and a two-hundred day moving average price of $75.09. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.45 and a current ratio of 2.33.

The company also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, July 31st. Stockholders of record on Wednesday, July 17th were issued a dividend of $0.10 per share. The ex-dividend date of this dividend was Tuesday, July 16th. Cantel Medical’s dividend payout ratio is 7.97%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Featured Article: How much can an individual set aside as a catch-up contribution?

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.